Pharmaceuticals is a technologically advanced and enormously competitive industry with a requirement for research that helps deliver real competitive advantage. As such, medical and healthcare market research requires an agency that can deliver top class response rates with high level respondents and patients alike.
We specialise in obtaining market information direct from the people who matter – industry experts, medical professionals, competitors, customers and patients – in order to answer the most difficult questions facing your business. Whether you wish to know the size and key segments of a target market, evaluate the competition, or understand how to tailor or better convey the advantages of your offering, we can help.
Healthcare Market Research and Healthcare surveys require an agency that delivers results. Insight Survey covers key areas in the healthcare and pharmaceutical sectors, and understanding patient needs, attitudes, preferences and future intentions is imperative for success in the healthcare industry.
Insight Survey’s market research services assist healthcare companies in understanding patient and healthcare professionals’ needs, tracking emerging health trends, and evaluating treatment preferences.
It also enables better product development, service delivery, and communication strategies by identifying gaps in care, testing new concepts, and assessing stakeholder satisfaction. Research also supports regulatory planning, pricing strategy, and competitive benchmarking, ultimately leading to improved patient outcomes, increased market share, and more effective resource allocation.
Insight Survey partnered with a multinational pharmaceutical company to evaluate the market potential in South Africa and assist in developing a marketing launch strategy for a new hypertension single pill combination therapy.
The client, a multinational pharmaceutical company sought to introduce a new single-pill combination therapy for hypertension in South Africa. However, there was limited insight into general practitioners’ (GPs) prescribing behaviour, treatment preferences, and the influence of patient demographics on treatment decisions. Understanding these elements was critical for market positioning, messaging, and adoption of the new product.
The research was conducted in two phases:
Phase 1 – Focus groups were held with GPs from both developed and emerging market profiles across South Africa. Discussions focused on guideline awareness, prescribing habits, and receptiveness to fixed-dose combination therapies, along with feedback on marketing concepts.
Phase 2 – A structured telephone survey was completed with GPs. The survey measured prescribing patterns for different demographic profiles, treatment preferences for monotherapy and dual therapy, and reactions to the proposed Indapamide SR + Amlodipine combination.
The research provided the client with a nuanced understanding of hypertension treatment approaches in South Africa. It highlighted strong interest in simplified, cost-effective therapies – especially among GPs in emerging areas – and underscored the importance of reimbursement and education in driving adoption. These findings informed product messaging, launch strategy, and positioning for the new single-pill combination therapy.
Based on the findings, the client was able to evaluate the effectiveness of their reps across product and region, as well as on an individual level. This allowed them to provide focused training for reps in order to improve communication effectiveness with Medical Practitioners.
Our team will respond within the next 24 hours, sooner if possible.
If the inquiry is more urgent, please call 021 045 0202 (Cape Town) or 010 140 5756 (Johannesburg).